GlassScriptPhysician profile
Roslyn R Grimsley
NPI 1093088023
$1,113.92
in general payments reported to CMS, 2019-2025
14 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.75 · 2023: $316 · 2024: $483 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $204.03 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $195.42 | 2024-2025 | |
| Lilly USA, LLC | $131.73 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Exact Sciences Corporation | $122.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $118.73 | 2023-2025 | Bexsero, Shingrix, Arexvy |
| Dexcom, INC. | $61.50 | 2023-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $54.89 | 2023-2024 | M-M-R II, Gardasil, Gardasil 9 |
| Dynavax Technologies Corporation | $53.60 | 2022-2024 | Heplisav-B |
| Sanofi-Aventis U.S. LLC | $44.96 | 2024 | |
| Abbott Laboratories | $36.16 | 2023-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $33.20 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $29.37 | 2023-2024 | Farxiga |
| Sanofi Pasteur INC. | $15.16 | 2025 | |
| Xeris Pharmaceuticals, INC. | $13.06 | 2023 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roslyn Grimsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.